{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:31:12Z","timestamp":1769211072186,"version":"3.49.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T00:00:00Z","timestamp":1393200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089878","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T22:11:47Z","timestamp":1393279907000},"page":"e89878","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Targeted Recombinant Fusion Proteins of IFN\u03b3 and Mimetic IFN\u03b3 with PDGF\u03b2R Bicyclic Peptide Inhibits Liver Fibrogenesis In Vivo"],"prefix":"10.1371","volume":"9","author":[{"given":"Ruchi","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"De Ruiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"key":"ref1","first-page":"275","article-title":"Gamma-interferon: physiology and speculation on its role in medicine","volume":"6","author":"EM Bonnem","year":"1987","journal-title":"JBiolResponse Mod"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"EC Borden","year":"2007","journal-title":"NatRevDrug Discov"},{"key":"ref3","first-page":"1051","article-title":"Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis","volume":"6","author":"D Bouros","year":"2006","journal-title":"ExpertOpinBiolTher"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"TE King Jr","year":"2009","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2007.06.022","article-title":"Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury","volume":"47","author":"B Knight","year":"2007","journal-title":"JHepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1046\/j.1523-1755.1999.00775.x","article-title":"Interferon-gamma inhibits experimental renal fibrosis","volume":"56","author":"SD Oldroyd","year":"1999","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","article-title":"Clinical Use of Interferon-gamma","volume":"1182","author":"CH Miller","year":"2009","journal-title":"AnnNYAcadSci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.21561","article-title":"Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis","volume":"45","author":"PJ Pockros","year":"2007","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2011.05.027","article-title":"PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis","volume":"154","author":"R Bansal","year":"2011","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"ref10","first-page":"1464","article-title":"Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres","volume":"13","author":"JL Cleland","year":"1996","journal-title":"PharmRes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2004.10.020","article-title":"Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer","volume":"102","author":"F Gu","year":"2005","journal-title":"JControl Release"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2011.04.008","article-title":"Targeted therapy of liver fibrosis\/cirrhosis and its complications","volume":"55","author":"K Poelstra","year":"2011","journal-title":"Journal of hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis \u2013 overview","volume":"254","author":"SL Friedman","year":"2008","journal-title":"Toxicology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-991517","article-title":"Hepatic fibrogenesis","volume":"27","author":"J Guo","year":"2007","journal-title":"SeminLiver Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"OA Gressner","year":"2007","journal-title":"Comp Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Y Popov","year":"2009","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.20476","article-title":"Stellate cells: a moving target in hepatic fibrogenesis","volume":"40","author":"SL Friedman","year":"2004","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"SL Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"GS Baroni","year":"1996","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"R Bansal","year":"2011","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","article-title":"Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury","volume":"88","author":"E Borkham-Kamphorst","year":"2008","journal-title":"Lab Invest"},{"key":"ref22","first-page":"1563","article-title":"Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture","volume":"94","author":"L Wong","year":"1994","journal-title":"JClinInvest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp200263q","article-title":"Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis","volume":"8","author":"R Bansal","year":"2011","journal-title":"Molecular pharmaceutics"},{"key":"ref24","first-page":"71","article-title":"Gamma interferon signaling: insights to development of interferon mimetics","volume":"52","author":"HM Johnson","year":"2006","journal-title":"Cell MolBiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/bi036213t","article-title":"Signal transduction mechanism of a peptide mimetic of interferon-gamma","volume":"43","author":"PS Subramaniam","year":"2004","journal-title":"Biochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"L Xu","year":"2005","journal-title":"Gut"},{"key":"ref27","first-page":"203","article-title":"A nitric oxide production bioassay for interferon-gamma","volume":"198","author":"YM Kim","year":"1996","journal-title":"JImmunolMethods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"MJ Arthur","year":"2000","journal-title":"AmJPhysiol GastrointestLiver Physiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells","volume":"21","author":"RC Benyon","year":"2001","journal-title":"SeminLiver Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhep.2009.10.007","article-title":"Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression","volume":"52","author":"A Schafer","year":"2010","journal-title":"JHepatol"},{"key":"ref31","first-page":"209","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"JClinInvest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"D Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1242\/jcs.00528","article-title":"The role of IFNgamma nuclear localization sequence in intracellular function","volume":"116","author":"CM Ahmed","year":"2003","journal-title":"JCell Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcp.20559","article-title":"Inhibition of collagen gene expression by interferon-gamma: novel role of the CCAAT\/enhancer binding protein beta (C\/EBPbeta)","volume":"207","author":"AK Ghosh","year":"2006","journal-title":"J Cell Physiol"},{"key":"ref35","first-page":"1307","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"L Beljaars","year":"2003","journal-title":"BiochemPharmacol"},{"key":"ref36","first-page":"571","article-title":"The molecular cell biology of interferon-gamma and its receptor","volume":"11","author":"MA Farrar","year":"1993","journal-title":"AnnuRevImmunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"L Beljaars","year":"2000","journal-title":"The Journal of biological chemistry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:02:03Z","timestamp":1565218923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089878"}},"subtitle":[],"editor":[{"given":"Rafael","family":"Aldabe","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089878","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]}}}